Symbol
| IL17RA
| contributors: npt/mct - updated : 13-09-2017
|
HGNC name
| interleukin 17 receptor A
|
HGNC id
| 5985
|
corresponding disease(s)
|
IMD51
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in gastric cancer tissues compared with adjacent normal tissues | tumoral
|  
|  
| --over
|  
|
in the invasive group of pituitary adenomas (pMID: 21279695) | |
Susceptibility
|
to ankylosing spondylitis (AS), severe form |
Variant & Polymorphism
| s4819554 minor allele G in the promoter of the IL17RA gene was associated with AS, severe form |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | colon | |
IL17A and IL17RA are therapeutic targets in colorectal cancer |
| | | |
| in the setting of influenza infection, IL17ra(-/-) mice showed significantly reduced levels of oxidized phospholipids, which have previously been shown to be an important mediator in several models of acute lung injury, including influenza infection |